Last edition
News about
Union Health Minister Launches National Action Plan on Antimicrobial Resistance 2.0
Union Minister of Health and Family Welfare Jagat Prakash Nadda on Tuesday (18 November) launched the second version of the National Action Plan on Antimicrobial Resistance (NAP-AMR 2025–29), reinforcing India’s commitment to combating the growing threat of AMR.
Biocon Pharma Receives US FDA Nod for Tofacitinib Extended-Release Tablets
Biocon Pharma has received approval from the US Food and Drug Administration (US FDA) for its ANDA for tofacitinib extended-release tablets, securing final approval for the 11 mg strength and tentative approval for the 22 mg strength.
Merus, Halozyme Partner to Develop Subcutaneous Petosemtamab
Under the agreement, Merus will pay Halozyme upfront and milestone-based payments, with Halozyme also eligible for low- to mid-single-digit royalties on future ENHANZE-enabled petosemtamab sales.
Accession Therapeutics Doses First Patient in Phase 1 Trial of TROCEPT-01
Accession Therapeutics has dosed the first patient in its Phase 1 trial of TROCEPT-01 (ATTR-01), a first-in-class tumour-activated viral immunotherapy. Designed for systemic delivery, the therapy aims to selectively generate a checkpoint inhibitor within tumours, offering a targeted approach to cancer treatment.
BPL Partners with ALPINION to Launch Next-Gen X CUBE 50 Ultrasound in India
BPL Medical Technologies, one of India’s leading medical equipment brands with a 50-year legacy, has partnered with ALPINION Medical Systems to introduce the X CUBE 50 ultrasound system from Korea to the Indian market.
Johnson & Johnson to Acquire Halda Therapeutics for USD 3.05 Billion
Johnson & Johnson has struck a definitive agreement to acquire Halda Therapeutics, a clinical-stage biotech company, for USD 3.05 billion in cash. Halda is known for its proprietary RIPTAC™ platform, which enables the development of oral, precision cancer therapies.
Zydus and SIG Sign Deal to Launch Single-Serve Spouted Pouches for Cough and Cold Medication
Zydus Lifesciences is introducing Deriphyllin CoughGo in single-serve spouted pouches utilising SIG’s advanced filling technology.
Lilly India Receives CDSCO Approval for Donanemab to Treat Early Alzheimer's Disease
Eli Lilly and Company (India) Pvt. Ltd. has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) for donanemab, a treatment for adults in the early symptomatic stages of Alzheimer’s disease.
EMA Enhances Scientific Advice Process for Medicines Targeting Public Health Threats
Under the new system, medicine developers can receive joint scientific advice from EMA and national clinical and ethics experts. This coordinated approach aligns trial and regulatory requirements early, helping accelerate trial approvals and access to critical medicines.
Vanda's Tradipitant Shows Strong Efficacy in Preventing Wegovy-Induced Nausea and Vomiting
Vanda Pharmaceuticals has announced positive topline results from its randomised controlled study evaluating tradipitant, an oral neurokinin-1 (NK-1) receptor antagonist, for preventing nausea and vomiting associated with GLP-1 receptor agonist Wegovy in overweight and obese adults.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy